@article{752d84787cf84c86bfbe2ebe7987b9e6,
title = "Considerations on the Role of Pembrolizumab Adjuvant Therapy in AJCC-8 Stage IIIA Melanoma Reply",
keywords = "Adjuvant therapy, Clinical trials, Hormonal therapy, Metastatic relapse, Risk of relapse, Stage at diagnosis, Staging systems, pembrolizumab",
author = "Eggermont, {Alexander M.M.} and Blank, {Christian U.} and Mario Mandala and Long, {Georgina V.} and Atkinson, {Victoria G.} and St{\'e}phane Dalle and Haydon, {Andrew M.} and Andrey Meshcheryakov and Adnan Khattak and Carlino, {Matteo S.} and Shahneen Sandhu and James Larkin and Susana Puig and Ascierto, {Paolo A.} and Piotr Rutkowski and Dirk Schadendorf and Rutger Koornstra and Leonel Hernandez-Aya and {Di Giacomo}, {Anna Maria} and {van den Eertwegh}, {Alfonsus J.M.} and Grob, {Jean Jacques} and Ralf Gutzmer and Rahima Jamal and Lorigan, {Paul C.} and {van Akkooi}, {Alexander C.J.} and Clemens Krepler and Nageatte Ibrahim and Sandrine Marreaud and Michal Kicinski and Stefan Suciu and Caroline Robert",
year = "2021",
month = mar,
day = "10",
doi = "10.1200/JCO.20.03463",
language = "English",
volume = "39",
pages = "944--946",
journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
issn = "0732-183X",
publisher = "Lippincott Williams & Wilkins",
number = "8",
}